InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: loanranger post# 208922

Monday, 12/18/2017 7:12:49 PM

Monday, December 18, 2017 7:12:49 PM

Post# of 403039
Hello LR. I have a different question and ask for your opinion on this statement:

As there are currently no approved drugs for prevention of severe OM in patients receiving chemoradiation treatment of HNC, management opinion is that Brilacidin-OM has the potential to rapidly assume a lead position after market introduction. This perspective is shared by multiple Pharma companies, potential partners the Company currently is in active discussions with, equally interested in the continued development and eventual market introduction of Brilacidin-OM worldwide.




I am not good with english and I know you are one that really focuses on each word and tense...etc....


So when they say "POTENTIAL PARTNERS THE COMPANY CURRENTLY IS IN ACTIVE DISCUSSIONS WITH..." is that referring to "This perspective is shared with multiple Pharma companies...": So they are detailing that Big Pharma and IPIX share the same opinion that B-OM will take the lead position? And those Big Pharmas are the ones they are currently discussing potential partnerships?

Play on...Playa
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News